Submit Article

Clinical Trials Imaging Techniques Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026

Interpretable human physiology and anatomy information plays an important role in both clinical and non-clinical trials for many years. Detecting, preventing and treating various ailments often fosters healthcare trends. Clinical references in terms of clinical imaging provide vital insights about drug effects. Hence clinical trial imaging market is flourishing particularly when it comes to research and drug development organisations. The global clinical trial imaging market is estimated to experience profitable growth during the forecast period from 2019 to 2026 registering global CAGR of 6.5%.

Potential upsurge in the number of pharma and biotechnology players, research organizations, increase in aged population with chronic diseases along with favourable R&D investments is expected to drive the growth clinical trial imaging market during the forecast period.

 

Clinical Trails Imaging Market Drivers Overview:

  1. Advancement in Imaging Technology

Numerous technology patents are being filled in an attempt to improve image capturing and evaluation by core imaging labs in order to speed up the development time for pharmaceutical organisations. Data accuracy, adaptability, consistency and compliance to clinical studies is possible due to the latest image analysis software. Advanced technology along with exceptional computation options enables rapid improvements in collection, assessment and submission of clinical trial data.

 

  1. Emerging Pharmaceutical and Biotechnology Industry

Medical imaging experiences fluctuations every now and then, yet numerous pharmaceutical and biotechnology companies continue to emerge. Also increasing investment in R&D for developing and discovering new drugs serves as a key driver in clinical trials imaging market upthrust.

 

  1. Mergers and Acquisitions

Not only investments in pharma and biotech firms but also the mergers and acquisitions among medical imaging companies are forging ways to enhance clinical trials imaging market.

 

  1. High-Cost Imaging Systems and Implementation Barriers

Adoption of innovative imaging technologies to support clinical trials for medical devices comes at a cost. Latest machinery, their installation, setting up mechanisms to transfer scans to a central location incur a high cost as well as high capital required to run clinical trials. Drug discoveries are augmenting the growth of clinical trials which involves imaging guidance documentation, managing quality assurance, performing quality control on scans received and the organization of independent radiological review and/or image analysis involves experts who need to be paid. These factors can restrain the growth of the market.

 

Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=109&page=requestsample

Clinical Trails Imaging Market Report Overview:

  • Imaging Type Segment   

o   Computed Tomography (CT) Scan

o    Magnetic Resonance Imaging (MRI)

o   X-Ray

o   Ultrasound

o   Echocardiography

  • End-Users

o   Bio-Pharmaceutical companies

o   Medical Devices Manufacturers

o   Academic Institutes

o   CROs i.e Contract Research Organizations

o   Hospitals

o   Others (cosmetics and skin care companies)

 Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=109&page=askfordiscount

 

Competitive Landscape:  

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

FutureWise Takeaways  

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

Objectives of the Study:

  • To provide with an exhaustive analysis on global clinical trials imaging market by imaging type, end-user and region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East
  • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • Profiling of companies to evaluate their market shares, strategies, financials and core competencies

 

Table of Contents

  1.   Introduction

1.1.    Scope and Objective

1.2.    Assumptions and Acronyms

1.3.    Forecast Factors

1.4.   Research Methodology

  1.    Executive Summary

2.1.    Industry Cluster Analysis

2.2.    Competition Matrix

2.3.    Strategies Recommendations

  1.   Market Definition

3.1.    Report Scope (Inclusions & Exclusions)

3.2.    Market Segmentation

  1.    Global Clinical Trials Imaging Techniques Market Overview 

4.1.    Global Clinical Trials Imaging Techniques Market Revenue (USD Mn)

  1.    Key Inclusions 

5.1.    Porter’s Five Force analysis

5.2.    Market Dynamics

5.3.    Industry Trends

5.4.    Regulatory Guidelines

5.5.   Opportunities in Clinical Trials Imaging Techniques

  1.    Competition Dynamics 

6.1.    Company Share Analysis (2018)

6.2.    Top 10 Product Pricing by Region

  1.    Global Clinical Trials Imaging Techniques Market Revenue (USD Mn), 2018-2026 by Imaging Type 

7.1.    Key Market Findings

7.2.    Long Term ROI Segments

7.3.    Revenue Opportunity Influencing Factors

7.4.    Market Revenue (USD Mn) Assessment and Forecast by Imaging Type, 2018-2026

7.4.1       CT

7.4.2       MRI

7.4.3       PET

7.4.4       Ultrasound

7.4.5       Echocardiography

7.4.6      X-Ray

  1.   Global Clinical Trials Imaging Techniques Market Revenue (USD Mn), 2018-2026 by End User 

8.1.    Key Market Findings

8.2.    Long Term ROI Segments

8.3.     Revenue Opportunity Influencing Factors

8.4.   Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026

8.4.1       BiopharmaceuticalCompanies

8.4.2       ContractResearch Organization

8.4.3       AcademicInstitutes

8.4.4       Hospitals

8.4.5       Medical DeviceManufactures

8.4.6       AcademicInstitutes

  1.   Global Clinical Trials Imaging Techniques Market Revenue (USD Mn), 2018-2026 by Region

9.1.    Key Market Findings

9.2.    Long Term ROI Segments

9.3.    Revenue Opportunity Influencing Factors

9.4.   Market Revenue (USD Mn) Assessment and Forecast by Region,2026

9.4.1       North America

9.4.2      Latin America

9.4.3      Europe

9.4.4      Asia Pacific

9.4.5      Rest of world

  1. North America Clinical Trials Imaging Techniques Market Revenue (US$ Mn), 2018-2026

10.1.   Key Market Findings

10.2.   Long Term ROI Segments

10.3.   Revenue Opportunity Influencing Factors

10.4.   Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026

10.4.1   US

10.4.2   Canada

10.5.   Market Revenue (USD Mn) Assessment and Forecast by Imaging Type, 2018-2026

10.5.3   CT

10.5.4   MRI

10.5.5   PET

10.5.6   Ultrasound

10.5.7   Echocardiography

10.5.8   X-Ray

10.6.   Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026

10.6.9   Biopharmaceutical Companies

10.6.10 Contract Research Organization

10.6.11 Academic Institutes

10.6.12 Hospitals

10.6.13 Medical Device Manufactures

10.6.14 Academic Institutes

  1. Latin America Clinical Trials Imaging Techniques Market Revenue (US$ Mn), 2018-2026

11.1.   Key Market Findings

11.2.   Long Term ROI Segments

11.3.   Revenue Opportunity Influencing Factors

11.4.   Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026

11.4.1   Brazil

11.4.2   Mexico

11.4.3   Argentina

11.4.4   Rest of Latin America

11.5.   Market Revenue (USD Mn) Assessment and Forecast by Imaging Type, 2018-2026

11.5.5   CT

11.5.6   MRI

11.5.7   PET

11.5.8   Ultrasound

11.5.9   Echocardiography

11.5.10X-Ray

11.6.   Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026

11.6.11Biopharmaceutical Companies

11.6.12 Contract Research Organization

11.6.13 Academic Institutes

11.6.14 Hospitals

11.6.15 Medical Device Manufactures

11.6.16 Academic Institutes

  1. Europe America Clinical Trials Imaging Techniques Market Revenue (US$ Mn), 2018-2026

12.1.   Key Market Findings

12.2.   Long Term ROI Segments

12.3.   Revenue Opportunity Influencing Factors

12.4.   Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026

12.4.1   Germany

12.4.2   France

12.4.3   Spain

12.4.4   UK

12.4.5   Russia

12.4.6   Poland

12.4.7   Rest of Europe

12.5.   Market Revenue (USD Mn) Assessment and Forecast by Imaging Type, 2018-2026

12.5.8   CT

12.5.9   MRI

12.5.10PET

12.5.11Ultrasound

12.5.12Echocardiography

12.5.13X-Ray

12.6.   Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026

12.6.14Biopharmaceutical Companies

12.6.15 Contract Research Organization

12.6.16 Academic Institutes

12.6.17 Hospitals

12.6.18 Medical Device Manufactures

12.6.19 Academic Institutes

  1. Asia Pacific America Clinical Trials Imaging Techniques Market Revenue (US$ Mn), 2018-2026

13.1.   Key Market Findings

13.2.   Long Term ROI Segments

13.3.   Revenue Opportunity Influencing Factors

13.4.   Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026

13.4.1   Emerging Asia

13.4.1.1          China

13.4.1.2          India

13.4.1.3          ASEAN-5

13.4.1.4          Rest of Emerging Asia

13.4.2   Japan

13.5.   Market Revenue (USD Mn) Assessment and Forecast by Imaging Type, 2018-2026

13.5.3   CT

13.5.4   MRI

13.5.5   PET

13.5.6   Ultrasound

13.5.7   Echocardiography

13.5.8   X-Ray

13.6.   Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026

13.6.9   Biopharmaceutical Companies

13.6.10 Contract Research Organization

13.6.11 Academic Institutes

13.6.12 Hospitals

13.6.13 Medical Device Manufactures

13.6.14 Academic Institutes

  1. Rest of World America Clinical Trials Imaging Techniques Market Revenue (US$ Mn), 2018-2026

14.1.   Key Market Findings

14.2.   Long Term ROI Segments

14.3.   Revenue Opportunity Influencing Factors

14.4.   Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026

14.4.1    Middle East

14.4.2    South Africa

14.4.3   North Africa

14.4.4   Rest of World

14.5.   Market Revenue (USD Mn) Assessment and Forecast by Imaging Type, 2018-2026

14.5.5   CT

14.5.6   MRI

14.5.7   PET

14.5.8   Ultrasound

14.5.9   Echocardiography

14.5.10X-Ray

14.6.   Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026

14.6.11Biopharmaceutical Companies

14.6.12 Contract Research Organization

14.6.13 Academic Institutes

14.6.14 Hospitals

14.6.15 Medical Device Manufactures

14.6.16 Academic Institutes

  1. Company Profiles

15.1.   Competition Landscape

15.2.   Global Company Share (USD Mn) Overview, 2018

15.3.   Company Profiles

15.3.1    GE Healthcare

15.3.1.1          Corporate Overview

15.3.1.2          Financial Performance

15.3.1.3          Peer Comparison & 3C marketing equation

15.3.1.4          Company Strategy & Channel Management

15.3.2    Siemens Healthcare

15.3.2.1          Corporate Overview

15.3.2.2          Financial Performance

15.3.2.3          Peer Comparison & 3C marketing equation

15.3.2.4          Company Strategy & Channel Management

15.3.3    Philips Healthcare

15.3.3.1          Corporate Overview

15.3.3.2          Financial Performance

15.3.3.3          Peer Comparison & 3C marketing equation

15.3.3.4          Company Strategy & Channel Management

15.3.4    Shimadzu Corporation

15.3.4.1          Corporate Overview

15.3.4.2          Financial Performance

15.3.4.3          Peer Comparison & 3C marketing equation

15.3.4.4          Company Strategy & Channel Management

15.3.5    Toshiba Medical Systems Corporation

15.3.5.1          Corporate Overview

15.3.5.2          Financial Performance

15.3.5.3          Peer Comparison & 3C marketing equation

15.3.5.4          Company Strategy & Channel Management

15.3.6    Carestream Health

15.3.6.1          Corporate Overview

15.3.6.2          Financial Performance

15.3.6.3          Peer Comparison & 3C marketing equation

15.3.6.4          Company Strategy & Channel Management

15.3.7    Hitachi Medical Corporation

15.3.7.1          Corporate Overview

15.3.7.2          Financial Performance

15.3.7.3          Peer Comparison & 3C marketing equation

15.3.7.4          Company Strategy & Channel Management

15.3.7.5

  1. Research Sources & Primary Verbatim

 

Inquire further details about this report at: sales@futurewiseresearch.com

About FutureWise Research:

We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future.

 

Contact Us:

Company Name: FutureWise Research
Contact Person:  Vinay Thaploo
Email: sales@futurewiseresearch.com
Phone: +44 141 628 9353 / +1 970 279 4295
City:  Leeds
Country:  United Kingdom
Website: www.futurewiseresearch.com

Article Estates
Logo
Shopping cart